Yeoksamdong, Seoul-t'ukpyolsi, South Korea Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Kitronyx | $870K | 01 Jun 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
infoplus | $5M | 20 Oct 2022 | Hanoi, Vietnam | ||
Umag | $4M | 26 May 2022 | South Korea, Gangwon-do, South Korea | ||
Vastera | $15M | 02 Mar 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Curamys | $8M | 25 Oct 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
AI FOR PET | $1M | 08 Sep 2021 | Pohang, Kyongsang-bukto, South Korea | ||
Motov | $9M | 07 Jun 2021 | South Korea, Gyeonggi-do, South Korea | ||
Plain Bagel | $2M | 24 May 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Amondz | $3M | 03 Jan 2020 | Seoul, Seoul-t'ukpyolsi, South Korea |
– Asalyxa Bio closed a $2m seed financing round to advance its lead program into first-in-human clinical trials.
– The financing was led by Research Bridge Partners, co-led by ID Ventures, and also included Michigan Rise Pre-Seed Fund III, BRCC of Western Michigan University, Ann Arbor Spark, Woodward Angels and other undisclosed investors.
– Proceeds from the financing will be used to advance Asalyxa Bio’s lead development candidate, ASX-100, into first-in-human clinical trials.
– Asalyxa Bio’s drug development programs are based on the company’s proprietary PANTHER technology platform, which enables the targeted delivery of therapeutic compounds directly to neutrophils and other key immune cells.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Kitronyx | $870K | 01 Jun 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
infoplus | $5M | 20 Oct 2022 | Hanoi, Vietnam | ||
Umag | $4M | 26 May 2022 | South Korea, Gangwon-do, South Korea | ||
Vastera | $15M | 02 Mar 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Curamys | $8M | 25 Oct 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
AI FOR PET | $1M | 08 Sep 2021 | Pohang, Kyongsang-bukto, South Korea | ||
Motov | $9M | 07 Jun 2021 | South Korea, Gyeonggi-do, South Korea | ||
Plain Bagel | $2M | 24 May 2021 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Amondz | $3M | 03 Jan 2020 | Seoul, Seoul-t'ukpyolsi, South Korea |
